» Articles » PMID: 11824584

A New Nonpeptide Tachykinin NK1 Receptor Antagonist Isolated from the Plants of Compositae

Overview
Specialties Chemistry
Pharmacology
Date 2002 Feb 5
PMID 11824584
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To find new tachykinin NK1 receptor antagonists from natural sources, we examined the tachykinin antagonist activity in the extracts of approximately 200 species of plants by the use of isolated guinea pig ileum. As a result, we discovered a novel and potent NK1 receptor antagonist in the extract of dried flowers of Matricaria chamomilla L. (chamomile). The structure of the antagonist was established as N1,N5,N10,N14-tetrakis[3-(4-hydroxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane (tetracoumaroyl spermine, 1a). The Ki values of 1a, estimated from the inhibitory action on the substance P (SP)-induced contraction of the guinea pig ileum and the inhibition of the binding of [3H][Sar9, Met(O2)11]SP to human NK1 receptors, were 21.9 nM and 3.3 nM, respectively. 1a is the first potent NK1 receptor antagonist from natural sources and it has a unique structure of a polyacylated spermine. 1a was concentrated in pollen of Matricaria chamomilla L. and was also found in the extracts of flowers of other four species of Compositae. In addition, we found N1,N5,N10-tris[3-(4-hydroxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane (2) as a new compound in the extract of flowers of Matricaria chamomilla L., which did not exhibit any tachykinin antagonist activity. A number of related compounds were synthesized, and the structure-activity relationship was studied.

Citing Articles

Comparative analysis of whole plant, flower and root extracts of L. and characteristic pure compounds reveals differential anti-inflammatory effects on human T cells.

Lairikyengbam D, Wetterauer B, Schmiech M, Jahraus B, Kirchgessner H, Wetterauer P Front Immunol. 2024; 15:1388962.

PMID: 38720895 PMC: 11077421. DOI: 10.3389/fimmu.2024.1388962.


Comparative Metabolomics of Ligulate and Tubular Flowers of Two Cultivars of L.

Ossipov V, Khazieva F, Baleev D, Salminen J, Sidelnikov N Metabolites. 2024; 14(3).

PMID: 38535300 PMC: 10972464. DOI: 10.3390/metabo14030140.


Phytochemical, Technological, and Pharmacological Study on the Galenic Dry Extracts Prepared from German Chamomile ( L.) Flowers.

Sepp J, Koshovyi O, Jakstas V, Zvikas V, Botsula I, Kireyev I Plants (Basel). 2024; 13(3).

PMID: 38337883 PMC: 10857454. DOI: 10.3390/plants13030350.


A Comprehensive Study of Therapeutic Applications of Chamomile.

Sah A, Naseef P, Kuruniyan M, Jain G, Zakir F, Aggarwal G Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297396 PMC: 9611340. DOI: 10.3390/ph15101284.


Putative Antidepressant Effect of Chamomile ( L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression.

Amsterdam J, Li Q, Xie S, Mao J J Altern Complement Med. 2019; 26(9):813-819.

PMID: 31808709 PMC: 7488203. DOI: 10.1089/acm.2019.0252.